Paul Mullan

Phone+44 (0)28 9097 2941
EmailP.Mullan@qub.ac.uk

Room 02.005 - CCRCB
United Kingdom

Accepting PhD Students

PhD projects

Dr Mullan's group is open to wide-ranging PhD applications from candidates with a basic science or clinical background. His fields of interest include: - Molecular Oncology - Cancer Biology and Signal Transduction - Drug discovery and development - Biomarkers, diagnosis and early detection of cancer Previous research experience is desirable although not essential.

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Paul Mullan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

70 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
3 Finished

R1944CNR: The identification and testing of blood markers to detect the presence of early ovarian stage cancers, speeding up patient diagnosis and ultimately improving patient survival.
Mullan, P. & Beirne, J. P.
06/09/2018 → …
Project: Research
R3511CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB
Harrison, T., Harkin, P., Johnston, P., Kennedy, R., Longley, D., Mullan, P., Prise, K., Salto-Tellez, M., Waugh, D., Williams, R. & Wilson, R.
01/08/2012 → 30/04/2016
Project: Research
R5771CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB
Waugh, D., Harkin, P., Johnston, P., Kennedy, R., Longley, D., Mullan, P., O'Sullivan, J., Prise, K., Salto-Tellez, M., Williams, R. & Wilson, R.
01/08/2012 → 30/04/2016
Project: Research
R1289CNR: Development of a Biomarker for the SRC Pathway in Ovarian Cancer
Kennedy, R. & Mullan, P.
01/08/2012 → 28/03/2015
Project: Research

60 Article
6 Meeting abstract
2 Other contribution
1 Letter
More
- 1 Review article

Development of a novel allograft model of prostate cancer: a new tool to inform clinical translation
Haughey, C. M., Mukherjee, D., Steele, R. E., Popple, A., Dura-Perez, L., Pickard, A., Jain, S., Mullan, P. B., Williams, R., Oliveira, P., Buckley, N. E., Honeychurch, J., Williams, R., McDade, S., Illidge, T., Mills, I. G. & Eddie, S. L., 2020
Research output: Other contribution

Open Access
Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer
Elkashif, A., Bingham, V., Haddock, P., Humphries, M., McQuaid, S., Mullan, P., McCarthy, H. & Buckley, N. E., 20 May 2020, In : Journal of Oncology.
Research output: Contribution to journal › Article › peer-review

Open Access
File
31 Downloads (Pure)
Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer
Haughey, C. M., Mukherjee, D., Steele, R. E., Popple, A., Dura-Perez, L., Pickard, A., Patel, M., Jain, S., Mullan, P. B., Williams, R., Oliveira, P., Buckley, N. E., Honeychurch, J., S McDade, S., Illidge, T., Mills, I. G. & Eddie, S. L., 29 Sep 2020, In : Cancers. 12, 10
Research output: Contribution to journal › Article › peer-review

Open Access
File
31 Downloads (Pure)
Pin1 plays a key role in the response to treatment and clinical outcome in Triple Negative Breast Cancer
Knowlson, C., Coulter, P., Bingham, V., McQuaid, S., Mullan, P. & Buckley, N. E., 09 Mar 2020, In : Therapeutic Advances in Medical Oncology.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Citations (Scopus)
Defining the molecular evolution of extrauterine high grade serous carcinoma
Beirne, J. P., McArt, D. G., Roddy, A., McDermott, C., Ferris, J., Buckley, N. E., Coulter, P., McCabe, N., Eddie, S. L., Dunne, P. D., O'Reilly, P., Gilmore, A., Feeney, L., Ewing, D. L., Drapkin, R. I., Salto-Tellez, M., Kennedy, R. D., Harley, I. J. G., McCluggage, W. G. & Mullan, P. B., 04 Sep 2019, In : Gynecologic Oncology. 155, 2, p. 305-317 13 p.
Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus)

1 Participation in Festival/Exhibition

International Mens Day Events, Faculty of Medicine, Health and Life Sciences
Sean Roe (Organiser), Paul Caplat (Member of the organising committee), Erin Davidson (Member of the organising committee), Maria Healy (Member of the organising committee), Mark Linden (Member of the organising committee), Simon McDade (Member of the organising committee), Declan McLaughlin (Member of the organising committee) & Paul Mullan (Member of the organising committee)
19 Nov 2020
Activity: Participating in or organising an event types › Participation in Festival/Exhibition

Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation
Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant) & Daniel Longley (Participant)
Impact: Health Impact, Quality of Life Impact